Morgan Stanley reduced its holdings in Zhongji Innolight (03308) by approximately 604,500 shares at a price of HKD 1,091.915 per share.
On July 31, Morgan Stanley reduced its holdings in Zhongji Xuchuang (03308) by 604,483 shares, at a price of HKD 1,091.915 per share, amounting to approximately HKD 660 million.
The latest data from the Hong Kong Stock Exchange shows that on July 31, Morgan Stanley reduced its holdings in Zhongji Innolight (03308) by 604,483 shares, with a per-share price of HKD 1,091.915, totaling approximately HKD 660 million. After the reduction, the latest number of shares held is about 3.4437 million, and the latest shareholding ratio is 6.31%.
Related Articles
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
CANBRIDGE-B(01228): Richard Arthur Moscicki has been appointed as an independent non-executive director.
US Stock Market Move | Biotech company Attovia Therapeutics (ATTO.US) debuted on NASDAQ, with its share price rising 28.82% on the first day of trading.
LEADS BIOLABS-B(09887): The phase II study of Weixin for the treatment of hepatocellular carcinoma has successfully entered the expansion stage.
RECOMMEND
